You are here: All Products  > Innovent Says NDA for Dual Agonist Obesity Therapy Accepted for China Review

Innovent Says NDA for Dual Agonist Obesity Therapy Accepted for China Review

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products